Solara Active Pharma Sciences Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2022
For the full year, sales was INR 12,683.4 million compared to INR 16,168.8 million a year ago. Revenue was INR 12,883.6 million compared to INR 16,456.5 million a year ago. Net loss was INR 581.5 million compared to net income of INR 2,214 million a year ago. Basic loss per share from continuing operations was INR 16.18 compared to basic earnings per share from continuing operations of INR 69 a year ago. Diluted loss per share from continuing operations was INR 16.18 compared to diluted earnings per share from continuing operations of INR 64.52 a year ago.